It’s Class I For June Recall Of Philips Breathing And Ventilator Devices
Executive Summary
The US FDA on 22 July designated a recent recall by Royal Philips of certain bi-level positive airway pressure (BiPAP), continuous positive airway pressure (CPAP), and other mechanical ventilator devices as high-risk class I.
You may also be interested in...
Philips Trilogy Evo Ventilators, Repair Kits Recalled Because Supplier Used Nonconforming Foam
Specific Trilogy Evo ventilators and their repair kits have been recalled because a Philips supplier incorrectly used polyester-based polyurethane (PE-PUR) foam, a nonconforming material, in the manufacture of their muffler assembly. The US FDA gave the recall a high-risk designation on 26 January.
Philips Releases Toxins Testing Results For Recalled DreamStation Breathing Device
Royal Philips says a first round of testing on its first generation DreamStation has found that the level of volatile organic compounds (VOCs) put off by the recalled device “is not typically anticipated to result in long-term health consequences for patients.”
After High-Risk Recall And Scathing Inspection Report, Is FDA Warning Letter Next For Philips?
Industry experts weigh in on what the US FDA’s enforcement options are following the company’s high-profile recall of millions of breathing devices and unfavorable facility inspection results.